We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tharimmune Inc | NASDAQ:THAR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0164 | -5.01% | 0.311 | 0.32 | 0.323 | 0.3699 | 0.3008 | 0.3335 | 1,044,423 | 00:59:19 |
THARIMMUNE, INC.
1200 Route 22 East, Suite 2000
Bridgewater, NJ 08807
November 7, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: | Delaying Amendment for Tharimmune, Inc. | |
Registration Statement on Form S-1 (File No. 333-275350) |
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-1(File No. 333-275350) filed with the Securities and Exchange Commission (the “Commission”) by Tharimmune, Inc. on November 6, 2023 (the “Registration Statement”). Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration Statement:
“The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.”
No fees are required in connection with this filing. If you have any questions or comments in connection with this delaying amendment, please contact our legal counsel Jeffrey Fessler at (212) 634-3067.
Sincerely, | ||
Tharimmune, Inc. | ||
/s/ Randy Milby | ||
By: | Randy Milby | |
Title: | Chief Executive Officer |
1 Year Tharimmune Chart |
1 Month Tharimmune Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions